Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Drugs

Loratadine-Darnitsa

Systemic antihistamines

Loratadine is a tricyclic antihistamine agent with selective activity against peripheral H1 receptors. In most patients, when administered at the recommended dose, loratadine does not have clinically significant sedative and anticholinergic effects.

Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.

Adults and children from the age of 12.

The drug should be used at a dose of 10 mg once per day.

Children aged from 2 to 12 years with a body weight of over 30 kg.

The drug should be used at a dose of 10 mg once per day.

Children aged from 2 to 12 years with a body weight of less than 30 kg.

Loratadine should be used in another dosage form.

Elderly patients and patients with renal impairment.

There is no need for dose adjustment.

Patients with impaired liver function.

Patients with severe hepatic impairment should be dose-adjusted due to a possible decrease in loratadine clearance (the recommended initial dose is 10 mg every other day).

Duration of treatment.

The duration of treatment is determined by the physician depending on the course of the disease.

Food intake does not affect the drug action.

Children.

The efficacy and safety of loratadine in children under 2 years have not been established.

The drug should be administered in children aged 2 years and over with a body weight of more than 30 kg.

Specialized edition for medical institutions and doctors.